After more than ten years, we are opening a new chapter: our oncological documentation software is entering the next generation, becoming more powerful, more modern, and ready for the demands of the future.
Why a change is necessary
ONKOSTAR 2 is based on technologies that are now outdated. Some key components will reach end of life by 2026 at the latest, meaning they will no longer be supported.
At the same time, demands for data protection, security, and integration with other systems are increasing. New legal requirements, such as the GDPR or the German Hospital Future Act (KHZG), are becoming increasingly difficult to implement with the current technical infrastructure.
To continue working in a legally compliant, stable, and future-proof manner, a fundamental change in technology is unavoidable.
Image source: ipuwadol – stock.adobe.com
What ONKOSTAR 3 offers
Version 3.0 represents a major technical and functional leap forward:
- Revision of the patient record
- New overviews for state cancer registry (LKR) reporting
- Bulk editing in research
- Direct R-Shiny integration for modern analyses
- Modernized user interface for a more pleasant and intuitive experience
- And much more
ONKOSTAR 3 is thus future-proof and lays the foundation for the next decade of your documentation work.
The path to the new version
ONKOSTAR 3 is currently in the testing phase, which is being gradually expanded to include clinical partners.
An official release is planned for October 2025.
The transition: simple and easy to plan
The transition to ONKOSTAR 3 was deliberately designed to integrate as smoothly as possible into your ongoing operations, without the need for complex data migration. All existing processes and data are retained.
Our conclusion
ONKOSTAR 3 offers everything modern oncological documentation needs: high user-friendliness, more interactivity, and flexibility based on a technically future-proof foundation.
We look forward to taking this next step with you! Please do not hesitate to contact us with any questions.
The ONKOSTAR Team
